Serum Metrnl is Decreased in Metabolic Dysfunction-Associated Fatty Liver Disease: A Case-Control Study

References

• Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73–84. doi:10.1002/hep.28431
   PubMed Web of Science ®Google Scholar
• Paik JM, Golabi P, Younossi Y, Mishra A, Younossi ZM. Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: the Growing Impact of NAFLD. Hepatology. 2020;72(5):1605–1616. doi:10.1002/hep.31173
   PubMed Web of Science ®Google Scholar
• Machado MV, Diehl AM. Pathogenesis of Nonalcoholic Steatohepatitis. Gastroenterology. 2016;150(8):1769–1777. doi:10.1053/j.gastro.2016.02.066
   PubMed Web of Science ®Google Scholar
• Eslam M, Newsome P, Sarin S, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73(1):202–209. doi:10.1016/j.jhep.2020.03.039
   PubMed Web of Science ®Google Scholar
• Kosekli MA, Kurtkulagii O, Kahveci G, et al. The association between serum uric acid to high density lipoprotein-cholesterol ratio and non-alcoholic fatty liver disease: the abund study. Rev Assoc Med Bras. 2021;67(4):549–554. doi:10.1590/1806-9282.20201005
   PubMed Web of Science ®Google Scholar
• Tarantino G, Balsano C, Santini SJ, et al. It Is High Time Physicians Thought of Natural Products for Alleviating NAFLD. Is There Sufficient Evidence to Use Them? Int J Mol Sci. 2021;22(24):13424. doi:10.3390/ijms222413424
   PubMed Web of Science ®Google Scholar
• Aktas G, Alcelik A, Ozlu T, et al. Association between omentin levels and insulin resistance in pregnancy. Exp Clin Endocrinol Diabetes. 2014;122(3):163–166. doi:10.1055/s-0034-1370917
   PubMed Web of Science ®Google Scholar
• Kocak MZ, Aktas G, Erkus E, et al. Neuregulin-4 is associated with plasma glucose and increased risk of type 2 diabetes mellitus. Swiss Med Wkly. 2019;149:w20139. doi:10.4414/smw.2019.20139
   PubMed Web of Science ®Google Scholar
• Kocak MZ, Aktas G, Atak BM, et al. Is Neuregulin-4 a predictive marker of microvascular complications in type 2 diabetes mellitus? Eur J Clin Invest. 2020;50(3):e13206. doi:10.1111/eci.13206
   PubMed Web of Science ®Google Scholar
• Pan J, Ding Y, Sun Y, et al. Associations between Adipokines and Metabolic Dysfunction-Associated Fatty Liver Disease Using Three Different Diagnostic Criteria. J Clin Med. 2023;12(6):2126. doi:10.3390/jcm12062126
   PubMed Web of Science ®Google Scholar
• Zheng SL, Li ZY, Song J, Liu JM, Miao CY. Metrnl: a secreted protein with new emerging functions. Acta Pharmacol Sin. 2016;37(5):571–579. doi:10.1038/aps.2016.9
   PubMed Web of Science ®Google Scholar
• Jung TW, Lee SH, Kim HC, et al. METRNL attenuates lipid-induced inflammation and insulin resistance via AMPK or PPARdelta-dependent pathways in skeletal muscle of mice. Exp Mol Med. 2018;50(9):1–11. doi:10.1038/s12276-018-0147-5
   Google Scholar
• Li ZY, Song J, Zheng SL, et al. Adipocyte Metrnl Antagonizes Insulin Resistance Through PPARgamma Signaling. Diabetes. 2015;64(12):4011–4022. doi:10.2337/db15-0274
   PubMed Web of Science ®Google Scholar
• Dadmanesh M, Aghajani H, Fadaei R, Ghorban K. Lower serum levels of Meteorin-like/Subfatin in patients with coronary artery disease and type 2 diabetes mellitus are negatively associated with insulin resistance and inflammatory cytokines. PLoS One. 2018;13(9):e0204180. doi:10.1371/journal.pone.0204180
   PubMed Web of Science ®Google Scholar
• Alizadeh H. Myokine-mediated exercise effects: the role of myokine meteorin-like hormone (Metrnl). Growth Factors. 2021;39(1–6):71–78. doi:10.1080/08977194.2022.2032689
   PubMed Web of Science ®Google Scholar
• Gong L, Huang G, Weng L, et al. Decreased serum interleukin-41/Metrnl levels in patients with Graves’ disease. J Clin Lab Anal. 2022;36(10):e24676. doi:10.1002/jcla.24676
   PubMed Web of Science ®Google Scholar
• Fouani FZ, Fadaei R, Moradi N, et al. Circulating levels of Meteorin-like protein in polycystic ovary syndrome: a case-control study. PLoS One. 2020;15(4):e0231943. doi:10.1371/journal.pone.0231943
   PubMed Web of Science ®Google Scholar
• Deniz R, Yavuzkir S, Ugur K, et al. Subfatin and asprosin, two new metabolic players of polycystic ovary syndrome. J Obstet Gynaecol. 2021;41(2):279–284. doi:10.1080/01443615.2020.1758926
   PubMedGoogle Scholar
• Du YN, Teng JM, Zhou TH, Du BY, Cai W. Meteorin-like protein overexpression ameliorates fulminant hepatitis in mice by inhibiting chemokine-dependent immune cell infiltration. Acta Pharmacol Sin. 2023;44(7):1404–1415. doi:10.1038/s41401-022-01049-4
   PubMed Web of Science ®Google Scholar
• Nugent C, Younossi ZM. Evaluation and management of obesity-related nonalcoholic fatty liver disease. Nat Clin Pract Gastroenterol Hepatol. 2007;4(8):432–441. doi:10.1038/ncpgasthep0879
   PubMedGoogle Scholar
• Chang ML, Yang Z, Yang SS. Roles of Adipokines in Digestive Diseases: markers of Inflammation, Metabolic Alteration and Disease Progression. Int J Mol Sci. 2020;21(21):8308. doi:10.3390/ijms21218308
   PubMed Web of Science ®Google Scholar
• Jimenez-Cortegana C, Garcia-Galey A, Tami M, et al. Role of Leptin in Non-Alcoholic Fatty Liver Disease. Biomedicines. 2021;9(7):762. doi:10.3390/biomedicines9070762
   PubMed Web of Science ®Google Scholar
• Heydari M, Cornide-Petronio ME, Jimenez-Castro MB, Peralta C. Data on Adiponectin from 2010 to 2020: therapeutic Target and Prognostic Factor for Liver Diseases? Int J Mol Sci. 2020;21(15):5242. doi:10.3390/ijms21155242
   PubMed Web of Science ®Google Scholar
• Finelli C, Padula MC, Martelli G, Tarantino G. Could the improvement of obesity-related co-morbidities depend on modified gut hormones secretion? World J Gastroenterol. 2014;20(44):16649–16664. doi:10.3748/wjg.v20.i44.16649
   PubMed Web of Science ®Google Scholar
• Otvos L Jr, Shao WH, Vanniasinghe AS, et al. Toward understanding the role of leptin and leptin receptor antagonism in preclinical models of rheumatoid arthritis. Peptides. 2011;32(8):1567–1574. doi:10.1016/j.peptides.2011.06.015
   PubMed Web of Science ®Google Scholar
• Alizadeh H. Meteorin-like protein (Metrnl): a metabolic syndrome biomarker and an exercise mediator. Cytokine. 2022;157:155952. doi:10.1016/j.cyto.2022.155952
   PubMed Web of Science ®Google Scholar
• Schmid A, Karrasch T, Schaffler A. Meteorin-Like Protein (Metrnl) in Obesity, during Weight Loss and in Adipocyte Differentiation. J Clin Med. 2021;10(19):4338. doi:10.3390/jcm10194338
   PubMed Web of Science ®Google Scholar
• Moradi N, Fadaei R, Roozbehkia M, et al. Meteorin-like Protein and Asprosin Levels in Children and Adolescents with Obesity and Their Relationship with Insulin Resistance and Metabolic Syndrome. Lab Med. 2023.
   Web of Science ®Google Scholar
• Miao ZW, Hu WJ, Li ZY, Miao CY. Involvement of the secreted protein Metrnl in human diseases. Acta Pharmacol Sin. 2020;41(12):1525–1530. doi:10.1038/s41401-020-00529-9
   PubMed Web of Science ®Google Scholar
• Grander C, Grabherr F, Enrich B, et al. Hepatic Meteorin-like and Kruppel-like Factor 3 are Associated with Weight Loss and Liver Injury. Exp Clin Endocrinol Diabetes. 2022;130(6):406–414. doi:10.1055/a-1537-8950
   PubMedGoogle Scholar
• Ren Z, Simons P, Wesselius A, Stehouwer CDA, Brouwers M. Relationship between NAFLD and coronary artery disease: a Mendelian randomization study. Hepatology. 2023;77(1):230–238. doi:10.1002/hep.32534
   PubMed Web of Science ®Google Scholar
• Chung HS, Hwang SY, Choi JH, et al. Implications of circulating Meteorin-like (Metrnl) level in human subjects with type 2 diabetes. Diabet Res Clin Pract. 2018;136:100–107. doi:10.1016/j.diabres.2017.11.031
   PubMed Web of Science ®Google Scholar
• Liu ZX, Ji HH, Yao MP, et al. Serum Metrnl is associated with the presence and severity of coronary artery disease. J Cell Mol Med. 2019;23(1):271–280. doi:10.1111/jcmm.13915
   PubMed Web of Science ®Google Scholar
• Ferns GA, Fekri K, Shahini Shams Abadi M, Banitalebi Dehkordi M, Arjmand MH. A meta-analysis of the relationship between serums metrnl-like protein/subfatin and risk of type 2 diabetes mellitus and coronary artery disease. Arch Physiol Biochem. 2021;1–7.
   Web of Science ®Google Scholar
• Zheng S, Li Z, Song J, et al. Endothelial METRNL determines circulating METRNL level and maintains endothelial function against atherosclerosis. Acta Pharm Sin B. 2023;13(4):1568–1587. doi:10.1016/j.apsb.2022.12.008
   PubMed Web of Science ®Google Scholar
• Ziegler MG. Atherosclerosis and Blood Pressure Variability. Hypertension. 2018;71(3):403–405. doi:10.1161/HYPERTENSIONAHA.117.10481
   PubMed Web of Science ®Google Scholar
• Zhou Y, Liu L, Jin B, et al. Metrnl Alleviates Lipid Accumulation by Modulating Mitochondrial Homeostasis in Diabetic Nephropathy. Diabetes. 2023;72(5):611–626. doi:10.2337/db22-0680
   PubMed Web of Science ®Google Scholar
• Wu H, Ballantyne CM. Skeletal muscle inflammation and insulin resistance in obesity. J Clin Invest. 2017;127(1):43–54. doi:10.1172/JCI88880
   PubMed Web of Science ®Google Scholar
• Wu H, Ballantyne CM. Metabolic Inflammation and Insulin Resistance in Obesity. Circ Res. 2020;126(11):1549–1564. doi:10.1161/CIRCRESAHA.119.315896
   PubMed Web of Science ®Google Scholar
• Ding X, Chang X, Wang J, et al. Serum Metrnl levels are decreased in subjects with overweight or obesity and are independently associated with adverse lipid profile. Front Endocrinol. 2022;13:938341. doi:10.3389/fendo.2022.938341
   PubMed Web of Science ®Google Scholar
• Loffler D, Landgraf K, Rockstroh D, et al. METRNL decreases during adipogenesis and inhibits adipocyte differentiation leading to adipocyte hypertrophy in humans. Int J Obes Lond. 2017;41(1):112–119. doi:10.1038/ijo.2016.180
   PubMed Web of Science ®Google Scholar
• Li ZY, Zheng SL, Wang P, et al. Subfatin is a novel adipokine and unlike Meteorin in adipose and brain expression. CNS Neurosci Ther. 2014;20(4):344–354. doi:10.1111/cns.12219
   PubMed Web of Science ®Google Scholar
• Wang C, Pan Y, Song J, et al. Serum Metrnl Level is Correlated with Insulin Resistance, But Not with beta-Cell Function in Type 2 Diabetics. Med Sci Monit. 2019;25:8968–8974. doi:10.12659/MSM.920222
   PubMed Web of Science ®Google Scholar
• Schuster S, Cabrera D, Arrese M, Feldstein AE. Triggering and resolution of inflammation in NASH. Nat Rev Gastroenterol Hepatol. 2018;15(6):349–364. doi:10.1038/s41575-018-0009-6
   PubMed Web of Science ®Google Scholar
• Wang S, Zhang C, Zhang G, et al. Association between white blood cell count and non-alcoholic fatty liver disease in urban Han Chinese: a prospective cohort study. BMJ Open. 2016;6(6):e010342. doi:10.1136/bmjopen-2015-010342
   PubMed Web of Science ®Google Scholar